Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to American Journal of Infection Control
- Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern.Lancet Infect Dis. 2008; 8: 159-166
- Multidrug-resistant bacteria in geriatric clinics, nursing homes, and ambulant care - prevalence and risk factors.Intl J Med Microbiol. 2013; 303: 405-409
- Multidrug-resistant bacteria colonization amongst patients newly admitted to a geriatric unit: a prospective cohort study.J Infect. 2012; 65: 109-118
2010 Census briefs. Available from: http://www.census.gov/prod/cen2010/briefs/c2010br-09.pdf. Accessed December 12, 2013.
- Extended-spectrum beta-lactamase producing Escherichia coli: changing epidemiology and clinical impact.Curr Opin Infect Dis. 2010; 23: 320-326
- Community-onset bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli: risk factors and prognosis.Clin Infect Dis. 2010; 50: 40-48
- First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system.Antimicrob Agents Chemother. 2007; 51: 4015-4021
- CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting.Am J Infect Control. 2008; 36: 309-332
- Approved Standard M100-S20.in: Performance standards for antimicrobial susceptibility testing; 20th informational supplement. The Clinical and Laboratory Standards Institute, Wayne [PA]2010
Approved standard M100-S19. In: Performance standards for antimicrobial susceptibility testing; 19th informational supplement. Wayne [PA]: Clinical and Laboratory Standards Institute; 2009.
- Molecular epidemiology of CTX-M-producing Escherichia coli isolates at a tertiary medical center in western Pennsylvania.Antimicrob Agents Chemother. 2009; 53: 4733-4739
- Risk factors for 28-day mortality in elderly patients with extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae bacteremia.Arch Gerontol Geriatr. 2014; 58: 105-109
- Extended-spectrum beta-lactamases: a clinical update.Clin Microbiol Rev. 2005; 18: 657-686
KSK is supported by the National Institute of Allergy and Infectious Diseases (Division of Microbiology and Infectious Diseases protocol No. 10-0065).
Conflicts of interest: KSK is a speaker, consultant, and recipient of grant support from Cubist and Pfizer.